BiosimulantBiosimulant
Docs
Search labs...
Sign inGet Started

Leon-Triana2021 - Competition between tumour cells and single-target CAR T-cells Lab

About lab

This model of the use of chimeric antigen receptor (CAR)-T cell therapy in the treatment of solid tumours is described in the article:'Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.

Runtime

Duration10
Comms Step1

Runs

Total0
Completed0
Failed0

Metadata

Packageleon-triana2021-competition-between-tumour-cells-and-single-targ
Created2026-05-15
Updated2026-05-15
immunologysbmlbiomodels_ebifaithfulcuratedvisualisation

Manifest

{
  "io": {
    "inputs": [
      {
        "name": "initial_car_t_cells",
        "label": "Initial Car T Cells",
        "units": "native source value",
        "default": 400000000,
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.initial_car_t_cells",
        "description": "Initial Car T Cells. Sets the initial value of bundled SBML species `CAR_T_cells`."
      },
      {
        "name": "initial_tumour_cells",
        "label": "Initial Tumour Cells",
        "units": "native source value",
        "default": 6700000000,
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.initial_tumour_cells",
        "description": "Initial Tumour Cells. Sets the initial value of bundled SBML species `Tumour_cells`."
      },
      {
        "name": "tumour_death_rate",
        "label": "Tumour Death Rate",
        "units": "unit_3",
        "default": 2.5e-10,
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.tumour_death_rate",
        "description": "Tumour Death Rate. Sets bundled SBML parameter `alpha_2`."
      }
    ],
    "outputs": [
      {
        "name": "car_t_cells",
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.car_t_cells"
      },
      {
        "name": "tumour_cells",
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.tumour_cells"
      },
      {
        "name": "state",
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.state"
      },
      {
        "name": "summary",
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.summary"
      },
      {
        "name": "species_labels",
        "maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.species_labels"
      }
    ]
  },
  "title": "Leon-Triana2021 - Competition between tumour cells and single-target CAR T-cells Lab",
  "models": [
    {
      "path": "owned/models/immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model",
      "alias": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model",
      "provenance": {
        "owned_path": "owned/models/immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model"
      }
    },
    {
      "path": "owned/models/visualisation",
      "alias": "visualisation",
      "provenance": {
        "owned_path": "owned/models/visualisation"
      }
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model_state"
      ],
      "from": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.state"
    },
    {
      "to": [
        "visualisation.immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model_summary"
      ],
      "from": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.summary"
    },
    {
      "to": [
        "visualisation.immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model_species_labels"
      ],
      "from": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.species_labels"
    }
  ],
  "runtime": {
    "duration": 10,
    "initial_inputs": {},
    "communication_step": 1
  },
  "description": "This model of the use of chimeric antigen receptor (CAR)-T cell therapy in the treatment of solid tumours is described in the article:'Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
  "schema_version": "2.0"
}

Sign in to start your own run. Public-lab history stays visible here.

Select a run from History to view its results.